News

Samin K. Sharma, MD, has been named Director of the Mount Sinai Cardiovascular Clinical Institute. In this new role within Mount Sinai Heart, Dr. Sharma will further enhance clinical care, operations, innovation, education, and clinical...

Boston Scientific Corporation announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2™ Aortic Valve System.

UC Davis Health has implemented Illuminate, Inc.’s Discovery 360 Services and ActKnowledge AI software. The goal is to identify existing patients in the UC Davis electronic health record who may have an abdominal aortic aneurysm and who need...

While it is well established that women with high blood pressure before or during pregnancy are at risk for cardiovascular disease later in life, very few studies have assessed cardiovascular risk for women who develop high blood pressure for...

An international study led by McMaster University researchers and published in The Lancet Global Health has found that influenza vaccines greatly reduce both pneumonia and cardiovascular complications in people with heart failure.

Impella RP Flex received FDA pre-market approval as being safe and effective to treat acute right heart failure for up to 14 days.

Shingles, also known as herpes zoster, is associated with an almost 30% higher long-term risk of a major cardiovascular event such a stroke or heart attack.

A potential new drug to improve the long-term outcomes for heart attack patients will be trialled in the UK.

Black patients who undergo minimally invasive procedures for clogged arteries are more likely to die or be readmitted to the hospital months after the procedure, a Michigan Medicine study finds.

A researcher at the University of Houston College of Pharmacy is reporting an effective protocol for reprogramming human heart cells into specialized cells that conduct electricity throughout the heart to enable rhythmic heartbeat and repair...